ID   PLCB4_HUMAN             Reviewed;        1175 AA.
AC   Q15147; B7ZLK6; E2QRH8; Q17R56; Q5JYS8; Q5JYS9; Q5JYT0; Q5JYT3;
AC   Q5JYT4; Q9BQW5; Q9BQW6; Q9BQW8; Q9UJQ2;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-DEC-2001, sequence version 3.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-beta-4;
DE   AltName: Full=Phospholipase C-beta-4;
DE            Short=PLC-beta-4;
GN   Name=PLCB4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=8530101; DOI=10.1006/geno.1995.1214;
RA   Alvarez R.A., Ghalayini A.J., Xu P., Hardcastle A., Bhattacharya S.,
RA   Rao P.N., Pettenati M.J., Anderson R.E., Baehr W.;
RT   "cDNA sequence and gene locus of the human retinal phosphoinositide-
RT   specific phospholipase-C beta 4 (PLCB4).";
RL   Genomics 29:53-61(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   THR-21.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-11; 79-88; 154-163; 181-195; 220-227; 255-266;
RP   366-377; 435-455; 516-528; 577-586; 606-717; 762-780; 786-797;
RP   822-847; 854-871; 883-908; 910-918; 1023-1039 AND 1139-1149, CLEAVAGE
RP   OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-886, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [6]
RP   VARIANTS ARCND2 THR-329; HIS-621; CYS-621; CYS-623 AND HIS-650.
RX   PubMed=22560091; DOI=10.1016/j.ajhg.2012.04.002;
RA   Rieder M.J., Green G.E., Park S.S., Stamper B.D., Gordon C.T.,
RA   Johnson J.M., Cunniff C.M., Smith J.D., Emery S.B., Lyonnet S.,
RA   Amiel J., Holder M., Heggie A.A., Bamshad M.J., Nickerson D.A.,
RA   Cox T.C., Hing A.V., Horst J.A., Cunningham M.L.;
RT   "A human homeotic transformation resulting from mutations in PLCB4 and
RT   GNAI3 causes auriculocondylar syndrome.";
RL   Am. J. Hum. Genet. 90:907-914(2012).
RN   [7]
RP   ERRATUM.
RA   Rieder M.J., Green G.E., Park S.S., Stamper B.D., Gordon C.T.,
RA   Johnson J.M., Cunniff C.M., Smith J.D., Emery S.B., Lyonnet S.,
RA   Amiel J., Holder M., Heggie A.A., Bamshad M.J., Nickerson D.A.,
RA   Cox T.C., Hing A.V., Horst J.A., Cunningham M.L.;
RL   Am. J. Hum. Genet. 90:1116-1116(2012).
CC   -!- FUNCTION: The production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is
CC       mediated by activated phosphatidylinositol-specific phospholipase
CC       C enzymes. This form has a role in retina signal transduction.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- INTERACTION:
CC       Q04864:REL; NbExp=3; IntAct=EBI-998637, EBI-307352;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=2;
CC         IsoId=Q15147-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q15147-2; Sequence=VSP_004721, VSP_004722;
CC       Name=3;
CC         IsoId=Q15147-4; Sequence=VSP_037818;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q15147-5; Sequence=VSP_055182;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in the retina.
CC   -!- DISEASE: Auriculocondylar syndrome 2 (ARCND2) [MIM:614669]: A
CC       craniofacial malformation syndrome characterized by variable
CC       mandibular anomalies, including mild to severe micrognathia,
CC       temporomandibular joint ankylosis, cleft palate, and a
CC       characteristic ear malformation that consists of separation of the
CC       lobule from the external ear, giving the appearance of a question
CC       mark (question-mark ear). Other frequently described features
CC       include prominent cheeks, cupped and posteriorly rotated ears,
CC       preauricular tags, and microstomia. {ECO:0000269|PubMed:22560091}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L41349; AAB02027.1; -; mRNA.
DR   EMBL; AL121898; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL121909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031652; CAI42213.1; -; Genomic_DNA.
DR   EMBL; AL023805; CAI42213.1; JOINED; Genomic_DNA.
DR   EMBL; AL023805; CAI43087.1; -; Genomic_DNA.
DR   EMBL; AL031652; CAI43087.1; JOINED; Genomic_DNA.
DR   EMBL; AL031652; CAI42218.2; -; Genomic_DNA.
DR   EMBL; AL023805; CAI42218.2; JOINED; Genomic_DNA.
DR   EMBL; AL023805; CAI43092.2; -; Genomic_DNA.
DR   EMBL; AL031652; CAI43092.2; JOINED; Genomic_DNA.
DR   EMBL; BC117458; AAI17459.1; -; mRNA.
DR   EMBL; BC143868; AAI43869.1; -; mRNA.
DR   CCDS; CCDS13104.1; -. [Q15147-4]
DR   CCDS; CCDS13105.1; -. [Q15147-1]
DR   CCDS; CCDS54447.1; -. [Q15147-5]
DR   RefSeq; NP_000924.3; NM_000933.3. [Q15147-4]
DR   RefSeq; NP_001166117.1; NM_001172646.1. [Q15147-5]
DR   RefSeq; NP_877949.2; NM_182797.2. [Q15147-1]
DR   RefSeq; XP_016883369.1; XM_017027880.1. [Q15147-4]
DR   RefSeq; XP_016883370.1; XM_017027881.1. [Q15147-1]
DR   UniGene; Hs.472101; -.
DR   ProteinModelPortal; Q15147; -.
DR   SMR; Q15147; -.
DR   BioGrid; 111348; 2.
DR   DIP; DIP-36735N; -.
DR   IntAct; Q15147; 3.
DR   STRING; 9606.ENSP00000334105; -.
DR   iPTMnet; Q15147; -.
DR   PhosphoSitePlus; Q15147; -.
DR   SwissPalm; Q15147; -.
DR   BioMuta; PLCB4; -.
DR   MaxQB; Q15147; -.
DR   PaxDb; Q15147; -.
DR   PeptideAtlas; Q15147; -.
DR   PRIDE; Q15147; -.
DR   Ensembl; ENST00000278655; ENSP00000278655; ENSG00000101333. [Q15147-1]
DR   Ensembl; ENST00000378473; ENSP00000367734; ENSG00000101333. [Q15147-5]
DR   Ensembl; ENST00000378493; ENSP00000367754; ENSG00000101333. [Q15147-1]
DR   Ensembl; ENST00000378501; ENSP00000367762; ENSG00000101333. [Q15147-4]
DR   Ensembl; ENST00000414679; ENSP00000390616; ENSG00000101333. [Q15147-5]
DR   GeneID; 5332; -.
DR   KEGG; hsa:5332; -.
DR   UCSC; uc010gbx.4; human. [Q15147-1]
DR   CTD; 5332; -.
DR   DisGeNET; 5332; -.
DR   GeneCards; PLCB4; -.
DR   HGNC; HGNC:9059; PLCB4.
DR   HPA; HPA007951; -.
DR   MalaCards; PLCB4; -.
DR   MIM; 600810; gene.
DR   MIM; 614669; phenotype.
DR   neXtProt; NX_Q15147; -.
DR   OpenTargets; ENSG00000101333; -.
DR   Orphanet; 137888; Auriculocondylar syndrome.
DR   PharmGKB; PA33387; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOGENOM; HOG000232046; -.
DR   HOVERGEN; HBG053609; -.
DR   InParanoid; Q15147; -.
DR   KO; K05858; -.
DR   OMA; NISFTYM; -.
DR   OrthoDB; EOG091G00XL; -.
DR   PhylomeDB; Q15147; -.
DR   TreeFam; TF352235; -.
DR   BRENDA; 3.1.4.11; 2681.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   ChiTaRS; PLCB4; human.
DR   GeneWiki; PLCB4; -.
DR   GenomeRNAi; 5332; -.
DR   PRO; PR:Q15147; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101333; -.
DR   ExpressionAtlas; Q15147; baseline and differential.
DR   Genevisible; Q15147; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome.
DR   GO; GO:0004629; F:phospholipase C activity; TAS:ProtInc.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR016280; PLC-beta.
DR   InterPro; IPR009535; PLC-beta_CS.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF06631; DUF1154; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PIRSF; PIRSF000956; PLC-beta; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 2.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Calcium; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transducer.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.4}.
FT   CHAIN         2   1175       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase beta-4.
FT                                /FTId=PRO_0000088495.
FT   DOMAIN      313    463       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      565    681       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      688    786       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   ACT_SITE    328    328       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    375    375       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.4}.
FT   MOD_RES     886    886       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ       1    153       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:8530101}.
FT                                /FTId=VSP_004721.
FT   VAR_SEQ     154    167       LAFMTNTNGKIPVR -> MNNNWNVCFFLFCP (in
FT                                isoform 1). {ECO:0000303|PubMed:8530101}.
FT                                /FTId=VSP_004722.
FT   VAR_SEQ     535    535       V -> VKKASDDLEHENN (in isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_055182.
FT   VAR_SEQ    1154   1175       AKEMQQMVKLEAEMDRRPATVV -> LLKSCHAVSQTQGEG
FT                                DAADGEIGSRDGPQTSNSSMKLQNAN (in isoform
FT                                3). {ECO:0000305}.
FT                                /FTId=VSP_037818.
FT   VARIANT      21     21       A -> T (in dbSNP:rs6077510).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_056694.
FT   VARIANT     329    329       N -> T (in ARCND2; dbSNP:rs387907179).
FT                                {ECO:0000269|PubMed:22560091}.
FT                                /FTId=VAR_068559.
FT   VARIANT     621    621       R -> C (in ARCND2; dbSNP:rs397514482).
FT                                {ECO:0000269|PubMed:22560091}.
FT                                /FTId=VAR_068560.
FT   VARIANT     621    621       R -> H (in ARCND2; dbSNP:rs397514481).
FT                                {ECO:0000269|PubMed:22560091}.
FT                                /FTId=VAR_068561.
FT   VARIANT     623    623       Y -> C (in ARCND2; dbSNP:rs397514480).
FT                                {ECO:0000269|PubMed:22560091}.
FT                                /FTId=VAR_068562.
FT   VARIANT     650    650       N -> H (in ARCND2; dbSNP:rs397514483).
FT                                {ECO:0000269|PubMed:22560091}.
FT                                /FTId=VAR_068563.
FT   VARIANT     710    710       G -> S (in dbSNP:rs6118603).
FT                                /FTId=VAR_056695.
FT   CONFLICT    447    447       A -> P (in Ref. 1; AAB02027).
FT                                {ECO:0000305}.
FT   CONFLICT    757    757       F -> L (in Ref. 1; AAB02027).
FT                                {ECO:0000305}.
FT   CONFLICT    787    787       L -> P (in Ref. 1; AAB02027).
FT                                {ECO:0000305}.
FT   CONFLICT    840    840       K -> T (in Ref. 1; AAB02027).
FT                                {ECO:0000305}.
FT   CONFLICT    902    902       A -> P (in Ref. 1; AAB02027).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1175 AA;  134464 MW;  AB2C8EB99EF57357 CRC64;
     MAKPYEFNWQ KEVPSFLQEG AVFDRYEEES FVFEPNCLFK VDEFGFFLTW RSEGKEGQVL
     ECSLINSIRS GAIPKDPKIL AALEAVGKSE NDLEGRIVCV CSGTDLVNIS FTYMVAENPE
     VTKQWVEGLR SIIHNFRANN VSPMTCLKKH WMKLAFMTNT NGKIPVRSIT RTFASGKTEK
     VIFQALKELG LPSGKNDEIE PTAFSYEKFY ELTQKICPRT DIEDLFKKIN GDKTDYLTVD
     QLVSFLNEHQ RDPRLNEILF PFYDAKRAMQ IIEMYEPDED LKKKGLISSD GFCRYLMSDE
     NAPVFLDRLE LYQEMDHPLA HYFISSSHNT YLTGRQFGGK SSVEMYRQVL LAGCRCVELD
     CWDGKGEDQE PIITHGKAMC TDILFKDVIQ AIKETAFVTS EYPVILSFEN HCSKYQQYKM
     SKYCEDLFGD LLLKQALESH PLEPGRALPS PNDLKRKILI KNKRLKPEVE KKQLEALRSM
     MEAGESASPA NILEDDNEEE IESADQEEEA HPEFKFGNEL SADDLGHKEA VANSVKKGLV
     TVEDEQAWMA SYKYVGATTN IHPYLSTMIN YAQPVKFQGF HVAEERNIHY NMSSFNESVG
     LGYLKTHAIE FVNYNKRQMS RIYPKGGRVD SSNYMPQIFW NAGCQMVSLN YQTPDLAMQL
     NQGKFEYNGS CGYLLKPDFM RRPDRTFDPF SETPVDGVIA ATCSVQVISG QFLSDKKIGT
     YVEVDMYGLP TDTIRKEFRT RMVMNNGLNP VYNEESFVFR KVILPDLAVL RIAVYDDNNK
     LIGQRILPLD GLQAGYRHIS LRNEGNKPLS LPTIFCNIVL KTYVPDGFGD IVDALSDPKK
     FLSITEKRAD QMRAMGIETS DIADVPSDTS KNDKKGKANT AKANVTPQSS SELRPTTTAA
     LASGVEAKKG IELIPQVRIE DLKQMKAYLK HLKKQQKELN SLKKKHAKEH STMQKLHCTQ
     VDKIVAQYDK EKSTHEKILE KAMKKKGGSN CLEMKKETEI KIQTLTSDHK SKVKEIVAQH
     TKEWSEMINT HSAEEQEIRD LHLSQQCELL KKLLINAHEQ QTQQLKLSHD RESKEMRAHQ
     AKISMENSKA ISQDKSIKNK AERERRVREL NSSNTKKFLE ERKRLAMKQS KEMDQLKKVQ
     LEHLEFLEKQ NEQAKEMQQM VKLEAEMDRR PATVV
//
